OncoHost Awarded €2.5 Million Grant from the EIC Transition Programme to Advance Precision Oncology for Patients Receiving Immunotherapy

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, together with its esteemed partners Heidelberg University Hospital, European Institute of Oncology and Virgen Macarena University Hospital, announced today the parties have been awarded a €2.5 Million grant from the EIC Transition Program of Horizon Europe. The grant received as a […]

NovoEd Introduces Mentor+, a Scalable Solution for Impactful 1:1 Learning, Mentoring, and Coaching in Today’s Organizations

AI-Driven Guidance and a Strategically Structured Process Expands Access and Engagement to Accelerate Skill Development and Institutional Knowledge NovoEd, the leading enterprise talent development technology provider, announces the launch of NovoEd Mentor+, a comprehensive and dynamic 1:1 learning platform for connecting people, fostering culture, boosting employee engagement, and cultivating future leaders through the power of

ROYAL CARIBBEAN GIVES THRILLING FIRST LOOK AT PERFECT DAY MEXICO, PLUS THREE MORE DESTINATION EXPERIENCES TO COME

From record-breaking firsts at the game-changing Perfect Day Mexico to ultimate beach days, vacationers can create the memories of a lifetime in more ways than ever before The world's boldest vacations are on the horizon as Royal Caribbean is raising the bar with its newly revealed Ultimate Destination lineup – with headliner Perfect Day Mexico*

EY US unveils Matthew Chang of Chang Robotics as an Entrepreneur Of The Year(R) 2025 Florida Award finalist

JACKSONVILLE, Fla. , May 15, 2025 (GLOBE NEWSWIRE) — Ernst & Young LLP (EY US) announced the finalists for the prestigious Entrepreneur Of The Year 2025 Florida Award. Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world's most ground-breaking companies, revolutionizing industries and

J. Thelander Consulting Launches First-Ever Compensation Trends & Planning Tool For The Global Private Capital Markets

Investment firms and private companies can now access strategic, real-time, and historical data that will enable them to outpace competitors, improve talent acquisition and retention, and succeed on a global level. J. Thelander Consulting, the leading source of compensation intelligence for private companies and investment firms, has announced a groundbreaking set of platform upgrades, including

Canadian Investment Regulatory Organization Trading Halt – SPTZ

The following issues have been halted by CIRO: Company: Spetz Inc. CSE Symbol: SPTZ All Issues:Yes Reason: Pending Clarification of News Halt Time (ET): 7:59 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and

Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets

Registration statement for proposed Cullgen merger declared effective by the SEC Proposed merger anticipated to close in June As part of proposed merger, Pulmatrix currently intends to divest its assets including its Phase 2-ready acute migraine candidate, PUR3100, and other development candidates based on its iSPERSE™ technology Pulmatrix, Inc.(“Pulmatrix” or the “Company”) (Nasdaq: PULM), a

Longevity Health Holdings Announces Business Updates

(NASDAQ:XAGE),(NASDAQ:XAGEW), PITTSBURGH and GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) — Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on extending human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“XAGE”, the “Company”, “we”, “our”, or “us”), today announced the following business updates: 1. Merger

IMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19

(NASDAQ:IMNN), Company's PlaCCine(R) technology platform demonstrates better durability and other advantages compared to mRNA vaccines Results further validate PlaCCine as a novel vaccine platform with potential applications in COVID-19 and other infectious diseases with epidemic implications LAWRENCEVILLE, N.J., May 15, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company focused on developing non-viral

Scroll to Top